Difficulty: Medium
Average Score: 68%
Practice
Situations that predispose a digitalis-treated patient to toxicity include
Correct answer
A
Rationale
In pharmacology, understanding the factors that predispose a patient to drug toxicity is crucial for safe medication administration. In the case of digitalis (digoxin) toxicity, hypercalcemia is a situation that can increase the risk.
**Rationale for Option A (Hypercalcemia):**
Hypercalcemia can potentiate the toxic effects of digitalis by increasing the sensitivity of the myocardium to the drug, leading to an increased risk of arrhythmias and other cardiac complications. Therefore, it is the correct answer in this scenario.
**Rationale for Options B, C, D (Hyperkalemia, Hypermagnesemia, None provided):**
- **Option B (Hyperkalemia):** Hyperkalemia is actually a condition that can mitigate the toxic effects of digitalis by counteracting its action on cardiac myocytes.
- **Option C (Hypermagnesemia):** Hypermagnesemia does not predispose a digitalis-treated patient to toxicity; in fact, magnesium deficiency can potentiate digitalis toxicity.
- **Option D (None provided):** This option is not applicable for analysis.
**Educational Context:**
Understanding the interactions and predisposing factors for digitalis toxicity is essential for healthcare professionals, especially in the context of managing cardiovascular conditions. By grasping these principles, clinicians can make informed decisions about medication dosages, monitoring parameters, and potential risks associated with digitalis therapy.
In conclusion, hypercalcemia is a significant factor that can predispose a digitalis-treated patient to toxicity, making it crucial for healthcare providers to be vigilant and monitor for this potential risk factor during treatment.
**Rationale for Option A (Hypercalcemia):**
Hypercalcemia can potentiate the toxic effects of digitalis by increasing the sensitivity of the myocardium to the drug, leading to an increased risk of arrhythmias and other cardiac complications. Therefore, it is the correct answer in this scenario.
**Rationale for Options B, C, D (Hyperkalemia, Hypermagnesemia, None provided):**
- **Option B (Hyperkalemia):** Hyperkalemia is actually a condition that can mitigate the toxic effects of digitalis by counteracting its action on cardiac myocytes.
- **Option C (Hypermagnesemia):** Hypermagnesemia does not predispose a digitalis-treated patient to toxicity; in fact, magnesium deficiency can potentiate digitalis toxicity.
- **Option D (None provided):** This option is not applicable for analysis.
**Educational Context:**
Understanding the interactions and predisposing factors for digitalis toxicity is essential for healthcare professionals, especially in the context of managing cardiovascular conditions. By grasping these principles, clinicians can make informed decisions about medication dosages, monitoring parameters, and potential risks associated with digitalis therapy.
In conclusion, hypercalcemia is a significant factor that can predispose a digitalis-treated patient to toxicity, making it crucial for healthcare providers to be vigilant and monitor for this potential risk factor during treatment.